U p to the end of the 1980s, the cause of about 30% of both type II and III mixed cryoglobulinemias (MC) in patients was not known, and this subgroup of patients were referred to as having essential mixed cryoglobulinemia. Essential mixed cryoglobulinemia was characterized clinically by systemic signs, mainly purpura, arthralgias, and fever, together with hepatic, neurologic, and renal symptoms. During this decade, antibodies against hepatitis C virus (HCV) antigens and HCV RNA (which is a marker of active viremia) have been detected in the serum of up to 90% of these patients.
During acute flare-ups, antiviral treatment (interferon-␣) is insufficient to control the renal disease, even when it reduces viremia. Steroids, usually associated with immunosuppressive drugs (cyclophosphamide), are then necessary to control renal disease.
Hepatitis C virus can infect B lymphocytes and stimulate them to synthesize the cryoprecipitating polyclonal rheumatoid factors responsible for type III MC. In some patients with this polyclonal B-cell activation, additional but as yet uncharacterized events might induce the shift to abnormal proliferation of a clone of B cells, producing a monoclonal IgM rheumatoid factor. Thus, a type II MC is induced that can be considered a lymphoproliferative disorder. It has been suggested that the IgMk produced by this permanent clone of B cells has affinity for the glomerular matrix and can deposit, in the glomerulus together with the IgG to which it binds in the blood, IgG that probably acts as an anti-HCV antigen antibody. 
CLASSIFICATION OF CRYOGLOBULINEMIAS AND ASSOCIATED DISEASES

FIGURE 9-1
Classification of cryoglobulinemias and associated diseases as proposed by Brouet and coworkers in 1974 [1] . Up to the end of the 1980s, the cause of about 30% of both types II and III mixed cryoglobulins was not clear, and this group of mixed cryoglobulinemias was called essential [2, 3] . As indicated in Figure 9 -4, it now is evident that most essential mixed cryoglobulinemias are associated with hepatitis C virus infection.
DETECTION OF CIRCULATING CRYOGLOBULINS AND DETERMINATION OF CRYOPRECIPITATE
Prewarm syringe, needle, and tubes at 37°C Take 20 mL of whole blood and put it immediately at 37°C Incubate for 2 h at 37°C to allow clotting Centrifuge twice at 1700 g X 10 at 37°C to discard platelets and erythrocytes Cryoglobulins precipitate reversibly from cooled serum Keep serum at 4°C in a conical graduate tube Look at the serum after 7 d Centrifuge serum at 400 g X 10 at 4°C and calculate the cryocrit as the percentage of packed cryoglobulins and serum ratio FIGURE 9-2 Correct methodology for detecting circulating cryoglobulins.
Cryoglobulins are immunoglobulins that precipitate reversibly from cooled serum.
A B FIGURE 9-3 (see Color Plate)
Immunoglobulin composition and clonality of mixed cryoglobulins characterized by immunofixation. The cryoglobulins (isolated, as indicated in Fig. 9-2 
PREVALENCE OF HEPATITIS C VIRUS AND HEPATITIS C VIRUS RNA IN ESSENTIAL AND SECONDARY MIXED CRYOGLOBULINEMIAS* Study
Ferri et al. [5] Galli et al. [6] Pechère-Bertschi et al. [7] Agnello et al. [8] Misiani et al. [9] Pasquariello et al. [10] Cacoub et al. [11] Bichard et al. [ 
Serum HCV antibodies
Serum HCV RNA FIGURE 9-4 Second-generation enzyme-linked immunosorbent assay has been used by all the authors listed here (with the exception of Agnello and coworkers [9] , who used a recombinant immunoblot assay) to measure anti-hepatitic C virus (HCV)
antibodies. The prevalence of positivity of HCV RNA in the 15 patients studied by Bichard and coworkers [12] increased from 60% to 93% when cryoprecipitate from serum was tested.
FREQUENT EXTRARENAL SIGNS IN PATIENTS WITH TYPES II AND III MIXED CRYOGLOBULINEMIA Signs and symptoms
Cutaneous purpura Arthralgias Fever Hepatosplenomegaly Neuropathy Abdominal pain
Prevalence during course of disease, %
FIGURE 9-5
Extrarenal signs frequently present in patients with types II and III mixed cryoglobulinemia, either essential or due to hepatitis C virus infection, with or without cryoglobulinemic nephropathy. In patients with cryoglobulinemic nephropathy, the systemic signs usually appear months or years before renal complications develop. The onset of these signs, however, may be concomitant with or even subsequent to the onset of renal signs. Abdominal pain is due to mesenteric vsasculitis [13] .
FIGURE 9-6
A purpuric rash of the legs in a patient with mixed cryoglobulinemia associated with hepatitis C virus infection.
DISTINCTIVE FEATURES OF MEMBRANOPROLIFERATIVE GLOMERULONEPHRITIS, OR CRYOGLOBULINEMIC GLOMERULONEPHRITIS
Exudative component
The major constituent of intracapillary proliferation is an infiltration of leukocytes, mainly monocytes, that sometimes is massive. Intraluminal thrombi Huge deposits of cryoglobulins called intraluminal thrombi sometimes fill the capillary lumen. Interposition of monocytes in the double contour of the capillary wall Monocytes, in close contact with the subendothelial deposits of cryoglobulins, are interposed between the glomerular basement membrane and the newly formed membranelike material, to give the double-contoured appearance of the capillary wall, whereas peripheral interposition of mesangial matrix and cells is moderate. Structured crystalloid deposits on electron microscopy Intraluminal and subendothelial deposits of cryoglobulins sometimes show a specific fibrillar structure on electron microscopy. Vasculitis of small and medium-sized arteries Necrotizing arteritis, without concomitant features of segmental necrotizing glomerulonephritis, is found in one third of patients.
FIGURE 9-7
The distinctive features of the membranoproliferative glomerulonephritis. This disorder, called cryoglobulinemic glomerulonephritis, occurs only in patients with type II mixed cryoglobulinemia, especially in the acute stage of the disease [4, 14] . In about 20% of patients with type II mixed cryoglobulinemia, a less distinctive picture of lobular membranoproliferation is found, whereas an additional 20% exhibit mild mesangial proliferation. These various types of histologic lesions can be found by repeat biopsies in the same patient during different stages of the disease.
FIGURE 9-8
Membranoproliferative exudative glomerulonephritis in patients with type II mixed cryoglobulinemia. The marked endocapillary hypercellularity also is due to massive intraglomerular infiltration of mononuclear leukocytes, mainly monocytes ( Fig. 9-9 ). Mesangial cell proliferation and mesangial matrix expansion are mild. Many loops show a thickened glomerular capillary wall, with frequent double-contoured basement membrane. (Trichrome stain ϫ 250.)
FIGURE 9-9
Immunohistochemical staining with anti-monocyte-macrophage antibody (CD68). This reaction confirms that the intracapillary hypercellularity is due mainly to accumulation of these mononuclear leukocytes. Their average number in acute stages of cryoglobulinemic glomerulonephritis is four times greater than in severe proliferative lupus nephritis [15] . (Immunoperoxidase ϫ 250.) 
FIGURE 9-12
Electron microscopy of subendothelial and endocapillary deposits showing an amorphous structure. In a minority of cases, as illustrated here, a specific annular and cylindrical structure is shown. This structure is identical to that seen in the in vitro precipitate of the same patients and consists of cylinders 100-to 1000-µm long, with a hollow axis, appearing in cross-sections as annular bodies [16] . (Uranyl acetate-lead citrate ϫ 22,000.) (Courtesy of Department of Pathology, San Carlo Borromeo Hospital, Milan, Italy.)
FIGURE 9-13
Silver stain showing the double-contoured appearance of the basement membrane. This morphologic aspect is diffuse and more clearly visible than in idiopathic membranoproliferative glomerulonephritis or lupus nephritis. (Silver stain ϫ 250.)
FIGURE 9-14
Interposition of monocytes in cryoglobulinemic glomerulnephritis. Two monocytes containing lysosomes are interposed, together with electron-dense subendothelial deposits, between the glomerular basement membrane and the newly formed basement-membrane-like material of the double-contoured capillary wall. The interposition of monocytes is a distinctive feature of cryoglobulinemic glomerulnephritis [17, 18] . Mesangial matrix and mesangial cell interposition, however, usually are less evident than in idiopathic membranoproliferative glomerulonephritis, as is glomerular sclerosis. (Uranyl acetate-lead citrate ϫ 8000.) (Courtesy of Department of Pathology, San Carlo Borromeo Hospital, Milan, Italy.)
FIGURE 9-15
Morphologic pattern of lobular glomerulonephritis. This pattern is present in 20% of cases, characterized by intense mesangial proliferation and peripheral mesangial matrix expansion associated with centrolobular sclerosis. This histologic picture is indistinguishable from that of idiopathic membranoproliferative glomerulonephritis type I, except for the presence of some degree of monocyte infiltration. (Trichrome ϫ 250.)
FIGURE 9-16
The glomerulus showing only mild mesangial proliferation and mesangial matrix expansion. Thickening of the glomerular basement membrane is not evident. This picture frequently is present in cases clinically characterized only by mild urinary abnormalities (inactive phase). Moreover, in many cases in which a biopsy is taken during the acute phase of the disease with typical membranoproliferative patterns with or without thrombi, a second renal biopsy will show clear regression of the morphologically acute lesions with only mild mesangioproliferative alteration. (Trichrome ϫ 250.) A B 
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Frequent histologic features
Membranoproliferative glomerulonephritis (MPGN), with moderate infiltration of monocytes Lobular MPGN Mesangioproliferative glomerulonephritis MPGN with leukocytic infiltration, or intraluminal thrombi owing to abrupt massive precipitation of cryoglobulins, usually associated with renal and systemic vasculitis, or both MPGN, frequently of lobular type, with some infiltration of monocytes
FIGURE 9-20
Renal syndrome at presentation in patients with cryoglobulinemic glomerulonephritis and associated histologic lesion. During the course of this disease, both the systemic and renal signs may vary remarkably, with periods of exacerbation alternating with periods of quiescence. Very often, exacerbation of the extrarenal signs is associated with exacerbation of renal disease (recurrent episodes of nephritic or nephrotic syndrome); however, a flare-up of renal disease may occur even in the absence of exacerbation of the extrarenal signs. Partial or total prolonged remission occurs spontaneously or after treatment in 10% to 15% of patients. Arterial hypertension frequently is severe and is present in most patients with cryoglobulinemic nephropathy.
LABORATORY ABNORMALITIES IN ESSENTIAL MIXED CRYOGLOBULINEMIA
Circulating cryoglobulins Cryocrits ranging from 2% to 70%, with large variations during the course of the disease Hypocomplementemia Very low levels of early C components (C1q and C4) and CH50; slightly low levels of C3; and high levels of late C components, C5 and C9
CLINICAL OUTCOMES OF 105 PATIENTS STUDIED IN THREE MILAN HOSPITALS FROM 1966 TO 1990
49% cumulative 10-year probability of survival, without renal failure 40% of patients died, mostly from cardiovascular diseases, liver failure, or infections 14% of patients progressed to chronic renal failure and required dialysis 14% of patients achieved complete and prolonged remission of renal symptoms
FIGURE 9-21
Relevant laboratory abnormalities in "essential" mixed cryoglobulinemia. During the course of this disease, cryoglobulins may temporarily become undetectable. Low levels of serum C4 cannot be corrected by treatment. Low levels of C3 frequently are found during clinical flare-ups and can be corrected by treatment.
FIGURE 9-22
The clinical outcomes in 105 patients studied in three hospitals in Milan, Italy, between 1966 and 1990. The medial total follow-up time from clinical onset was approximately 11 years [19] .
TREATMENT OF ACUTE RENAL EXACERBATIONS OF CRYOGLOBULINEMIC GLOMERULONEPHRITIS AND VASCULITIS
Steriods are used to control inflammatory renal and systemic involvement Cytotoxic drugs are used to block production of new cryoglobulins by the specific lymphocytic clone that produces the monoclonal immunoglobulin Mk RF, and therefore, the precipitating cryoglobulins Plasma exchange is used to remove circulating cryoglobulins from the blood before they deposit in the glomerulus and arterial walls
FIGURE 9-23
This approach to treatment of the acute renal exacerbations of cryoglobulinemia and vasculitis used previously when the viral cause of the disease was unknown is still valid now that the viral cause is evident. It is a common experience that the antiviral agent interferon-␣, when given alone, does not control renal complications in the acute stage of the disease [20] .
PROPOSED TREATMENT FOR MIXED CRYOGLOBULINEMIA ASSOCIATED WITH HEPATITIS C VIRUS INFECTION Drug
Interferon-␣ Steriods Cyclophosphamide Plasmapheresis 
FIGURE 9-24
The proposed treatment for mixed cryoglobulinemia associated with hepatitis C virus infection in the presence of severe acute signs of renal involvement, ie, glomerulonephritis and vascultits. Plasma exchange is used only when acute renal insufficiency caused by massive precipitation of cryoglobulins is present. Interferon-␣ is given for more than 6 months only when negation of hepatitis C virus RNA is achieved in the first months, suggesting a beneficial effect on the viremia. Only the antiviral treatment with interferon-␣ eventually associated with low doses of steriods to conrol the systemic signs of mixed cryoglobulinemias should be given if renal involvement is mild. The association of interferon-␣ with another antiviral agent ribavirin, 0.6 to 1.0 g/d orally, now is being tested in patients with hepatitis C virus infection, with promising results [20] . 
FIGURE 9-25
The mechanisms of renal complications induced by hepatitis C virus (HCV) infection, with or without associated mixed cryoglobulinemia, according to our hypothesis. As illustrated, the prevalent pathogenetic mechanism is the deposition in the glomerulus of a monoclonal IgM rheumatoid factor (RF) with particular affinity for the glomerular matrix, which is produced by permanent clones of B lymphocytes infected by HCV. It is unknown whether the IgM RF deposits in the glomerulus alone, with subsequent in situ binding of IgG (perhaps bound already to viral antigens, or as a complex composed of HCV antigens, IgG anti-HCV antibodies, and IgMk RF). Only recently have specific HCV-related proteins been detected in glomerular structures using indirect immunochemistry. As depicted on the left, it is possible that in a minority of cases immune complexes composed of HCV antigens and anti-HCV IgG antibodies can deposit directly in the glomerular structures, in the absence of a concomitant type II MC with a monoclonal IgM RF. This deposition induces an immune-complex glomerulonephritis similar to that described in patients infected with the hepatitis B virus. (Adapted from D'Amico [21] .)
